Company Announcements

JPMC&Co. Form 8-K dated February 25, 2020

Source: RNS
RNS Number : 1229E
JPMorgan Chase & Co
25 February 2020
 

Regulatory Announcement

JPMorgan Chase & Co.

February 25, 2020

JPMorgan Chase & Co. has submitted the following document to the National Storage Mechanism of the UK Financial Conduct Authority:

•     Current Report on Form 8-K of JPMorgan Chase & Co. dated February 25, 2020 containing the slides furnished for an investor presentation held on February 25, 2020 in connection with JPMorgan Chase & Co.'s Investor Day, as furnished to the U.S. Securities and Exchange Commission

This Current Report on Form 8-K may also be viewed on the U.S. Securities and Exchange Commission's website (www.sec.gov) and on JPMorgan Chase & Co.'s investor relations website (https://jpmorganchaseco.gcs-web.com/financial-information/sec-filings).

For further information, please contact:

Molly Carpenter

Corporate Secretary

JPMorgan Chase & Co.

Telephone number: +001 212 270 6000

Fax number: +001 212 270 4240

Email: molly.carpenter@jpmchase.com

 

DISCLAIMER -- INTENDED ADDRESSEES

 

Please note that the information contained in the above mentioned document(s) may be addressed to and/or targeted at persons who are residents of particular countries (specified in such document(s)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom such document(s) is not addressed. Prior to relying on the information contained in such document(s) you must ascertain from the document(s) whether or not you are part of the intended addressees of the information contained therein. 

 

Your right to access this service is conditional upon complying with the above requirement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCTAMJTMTBTTBM